Abstract
Coronary artery disease (CAD) is the largest cause of morbidity and mortality in the world. A relationship between CAD and elevated levels of low-density lipoprotein cholesterol has been established. However, risk assessment limited to low-density lipoprotein fails to identify a significant portion of patients at risk for CAD. Remnant lipoproteins, derived from very low-density lipoprotein and chylomicrons, have been considered atherogenic. Recently, a simple and reliable immunoaffinity separation method for the isolation of remnant-like particles (RLP) has been developed. It has been shown that RLP cholesterol levels are significantly correlated with CAD, and thus cellular mechanisms have been determined by which RLP cholesterol causes progression of atherosclerosis. Measurement of RLP cholesterol is useful for the assessment of risk and the evaluation of therapy in patients at risk for CAD.
References
Dec 31, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·K NakajimaE Campos
Apr 1, 1996·Journal of Cardiovascular Risk·J E Hokanson, M A Austin
Jun 17, 1998·The American Journal of Medicine·S DevarajI Jialal
Jul 10, 1998·Circulation·K KugiyamaH Yasue
Jun 9, 1999·Circulation·K KugiyamaH Yasue
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J S CohnJ Davignon
Feb 19, 2000·Current Opinion in Lipidology·G F Watts, S B Dimmitt
Jun 22, 2000·Circulation·M A AustinA G Motulsky
Aug 10, 2000·Circulation·H DoiH Yasue
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Dec 18, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·D T SteinI Jialal
Aug 15, 2002·Circulation·Pernette R W de Sauvage NoltingUNKNOWN Examination of Probands and Relatives in Statin Studies with Familial Hypercholesterolemia (ExPRESS) Study Group
Feb 6, 2004·Circulation·Scott M GrundyUNKNOWN American Diabetes Association
Jun 15, 2004·Journal of the American College of Cardiology·Hironobu FukushimaKiyotaka Kugiyama
Aug 17, 2004·American Heart Journal·Philippe O Szapary, Daniel J Rader
Jul 26, 2005·Atherosclerosis·Takamitsu NakamuraKiyotaka Kugiyama
Citations
Apr 3, 2009·Journal of Human Hypertension·A SoliniE Ferrannini
May 24, 2007·Current Medical Research and Opinion·Stephen Brunton, Nancy Collins
Sep 28, 2010·Atherosclerosis·Claire GavinUNKNOWN Diabetes Aerobic and Resistance Exercise (DARE) trial investigators
Dec 1, 2008·Journal of Clinical Lipidology·Dirk J BlomElinor Miller
Feb 20, 2008·Atherosclerosis·Yo AramakiNoriaki Kume
Nov 18, 2006·Clinics in Laboratory Medicine·Krishnaji R Kulkarni
May 23, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Wei-Jian BeiYang Cao
May 30, 2015·Journal of the American College of Cardiology·Gregory G SchwartzAnders G Olsson
Feb 23, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kenta MoriKen-ichi Hirata
May 9, 2007·Journal of Atherosclerosis and Thrombosis·Yoshinobu NakadaKatsunori Ikewaki
Jun 10, 2017·Clinical Pharmacology in Drug Development·Yoshinori NodaToshitaka Yajima
Jan 27, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Linda S ZhangPatrick Tso
Mar 13, 2019·International Journal of Molecular Sciences·Hidekatsu Yanai, Hiroshi Yoshida
Apr 8, 2010·Molecular Biology Reports·Li-Li ShenYu Jiang
Jun 12, 2020·Lipids in Health and Disease·Jin ChenBilian Yu
Jan 13, 2016·Endocrinology and Metabolism·Hyo Sun LeeUNKNOWN PROPIT study team
Mar 18, 2020·Lipids in Health and Disease·Xunxun FengYujie Zhou